
Hyperthermia in Breast Cancer: 2024 Breakthroughs
Exciting progress in breast cancer treatment emerged in 2024, with hyperthermia—a heat-based therapy—gaining momentum as an innovative adjuvant approach. Research and clinical trials last year
We offer breast cancer treatment by hyperthermia therapy using our proprietary hardware and software that use advanced analysis and adjustment algorithms and image processing techniques.
ThermoOncology enables a safe and effective treatment for breast cancer using targeted microwave therapy.
Combining our propriety software, TO-Plan, and hardware, the TO-M1, which use advanced algorithms and imaging, ThermoOncology plans, optimizes, targets, and executes on microwave hyperthermia therapy to mitigate breast cancer tumors.
At ThermoOncology we are dedicated to bring safe and effective cancer therapy, hyperthermia therapy, to breast cancer treatment
TO-M1 uses cameras and a specially tailored material in order to stabilize and correctly target treatment as defined during planning.
Precise region shape and depth of penetration analysis by using a combination of our proprietary wideband antenna and software
Image processing algorithm to interpret, segment, and 3D model a computational phantom of the patient using standard CT and photo imaging data.
In hyperthermia therapy, the whole or part of the patient body is subjected to a temperature in range of 40-44 ºC for specific periods of time.
Since tumor cells are more sensitive to temperatures in this range, as compared to normal tissue cells, these cells are the ones that get damaged by high temperatures in this therapy.
In order to have a successful treatment outcome, it is essential to control the target cells’ temperature. Our imaging-based micro-adjustment algorithms, uses positioning, pressure, and imaging data to make corrections to the treatment in real time as the breast moves or changes shape
Read our blog to find out more about Hyperthermia therapy in cancer treatment
Exciting progress in breast cancer treatment emerged in 2024, with hyperthermia—a heat-based therapy—gaining momentum as an innovative adjuvant approach. Research and clinical trials last year
🚀 Exciting News from ThermoOncology! 🚀 Dear #ThermoOncology followers, We are thrilled to announce our participation in TechnoNet Summit3, the premier event for startups, innovation,
Dear ThermoOncology followers, #ThermoOncology has been invited to join the ALPHA startup program at Web Summit Vancouver 2025 – recognized by Politico as the “world’s
Dear ThermoOncology followers, MIT researchers have developed “Mirai,” an AI model that detects breast cancer up to five years before clinical diagnosis. Yes, … 5
Dear Thermo Oncology followers, A recent development in Breast Cancer Diagnosis with AI is amazing. Ductal carcinoma in situ (DCIS) accounts for 25% of breast
Dear ThermoOncology Followers, In this post, we are discussing about the active clinical trials in the Hyperthermia treatment research in the US and Canada. If
We are here to help cancer patients throughout the world. Contact us and we will respond to your inquiry within 24 hours.
ThermoOncology offers a specialized hardware/software platform that uses advanced algorithms and imaging to plan, optimize, target, and execute on microwave hyperthermia therapy to mitigate breast cancer tumors.